Yahoo Web Search

Search results

    • Gateway - Quartz

      Quartz· 4 days ago

      After dominating the market for weight loss drugs, Ozempic maker Novo Nordisk has set its sights on tackling treatments for heart disease next. Cardior, a Germany-based drug

    • Gateway - Quartz

      Quartz· 5 days ago

      The Danish pharma giant is one-half of the current duopoly on GLP-1 (glucagon-like peptide 1) agonist medications, a class of drugs that helps regulate blood sugar levels and suppresses a user ...